发明授权
EP2029602B1 TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
有权
TRIAZOLOPYRAZINVERBINDUNGEN用于治疗退化性疾病和炎性疾病
- 专利标题： TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
- 专利标题（中）： TRIAZOLOPYRAZINVERBINDUNGEN用于治疗退化性疾病和炎性疾病
-
申请号： EP07729660.6申请日： 2007-05-30
-
公开(公告)号： EP2029602B1公开(公告)日： 2010-04-21
- 发明人: ANDREWS, Martin James Inglis , EDWARDS, Paul , CHAMBERS, Mark Stuart , SCHMIDT, Wolfgang , CLASE, Juha Andrew , BAR, Gregory , HIRST, Kim Louise , MACLEOD, Angus
- 申请人： Galapagos N.V.
- 申请人地址： Generaal de Wittelaan L11 A3 2800 Mechelen BE
- 专利权人： Galapagos N.V.
- 当前专利权人： Galapagos N.V.
- 当前专利权人地址： Generaal de Wittelaan L11 A3 2800 Mechelen BE
- 代理机构： Nichol, Maria Zenarosa
- 优先权： US803552P 20060531; US931764P 20070525; US931844P 20070525; US931763P 20070525; US932100P 20070529
- 国际公布： WO2007138072 20071206
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/4985 ; A61P29/00
摘要：
Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following (formula I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.
公开/授权文献
信息查询
